BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17767008)

  • 1. Utility of family history reports of major birth defects as a public health strategy.
    Romitti PA
    Pediatrics; 2007 Sep; 120 Suppl 2():S71-7. PubMed ID: 17767008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linking family history in obstetric and pediatric care: assessing risk for genetic disease and birth defects.
    Dolan SM; Moore C
    Pediatrics; 2007 Sep; 120 Suppl 2():S66-70. PubMed ID: 17767007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using birth defects registry data to evaluate infant and childhood mortality associated with birth defects: an alternative to traditional mortality assessment using underlying cause of death statistics.
    Copeland GE; Kirby RS
    Birth Defects Res A Clin Mol Teratol; 2007 Nov; 79(11):792-7. PubMed ID: 17990340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved national prevalence estimates for 18 selected major birth defects--United States, 1999-2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Jan; 54(51):1301-5. PubMed ID: 16397457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is family history a useful tool for detecting children at risk for diabetes and cardiovascular diseases? A public health perspective.
    Valdez R; Greenlund KJ; Khoury MJ; Yoon PW
    Pediatrics; 2007 Sep; 120 Suppl 2():S78-86. PubMed ID: 17767009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for a public health response to birth defects clusters.
    Williams LJ; Honein MA; Rasmussen SA
    Teratology; 2002; 66 Suppl 1():S50-8. PubMed ID: 12239745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Summary of workgroup meeting on use of family history information in pediatric primary care and public health.
    Green RF
    Pediatrics; 2007 Sep; 120 Suppl 2():S87-100. PubMed ID: 17767010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinician reviewers in birth defects surveillance programs: survey of the National Birth Defects Prevention Network.
    Lin AE; Forrester MB; Cunniff C; Higgins CA; Anderka M
    Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):781-6. PubMed ID: 17051528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDC Grand Rounds: Understanding the Causes of Major Birth Defects - Steps to Prevention.
    Simeone RM; Feldkamp ML; Reefhuis J; Mitchell AA; Gilboa SM; Honein MA; Iskander J
    MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(39):1104-7. PubMed ID: 26447345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimates of the economic costs of birth defects.
    Waitzman NJ; Romano PS; Scheffler RM
    Inquiry; 1994; 31(2):188-205. PubMed ID: 8021024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical issues raised by incorporation of genetics into the National Birth Defects Prevention Study.
    Jenkins MM; Rasmussen SA; Moore CA; Honein MA
    Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):40-6. PubMed ID: 18189287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology and prevention of congenital cytomegalovirus infection and disease: activities of the Centers for Disease Control and Prevention Workgroup.
    Ross DS; Dollard SC; Victor M; Sumartojo E; Cannon MJ
    J Womens Health (Larchmt); 2006 Apr; 15(3):224-9. PubMed ID: 16620180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Awareness of family health history as a risk factor for disease--United States, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Nov; 53(44):1044-7. PubMed ID: 15538320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic costs of birth defects and cerebral palsy--United States, 1992.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1995 Sep; 44(37):694-9. PubMed ID: 7666849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collection, use, and protection of population-based birth defects surveillance data in the united states.
    Mai CT; Law DJ; Mason CA; McDowell BD; Meyer RE; Musa D;
    Birth Defects Res A Clin Mol Teratol; 2007 Dec; 79(12):811-4. PubMed ID: 18064713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer risk in children with birth defects and in their families: a population based cohort study of 5.2 million children from Norway and Sweden.
    Bjørge T; Cnattingius S; Lie RT; Tretli S; Engeland A
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):500-6. PubMed ID: 18296646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical geneticists in birth defects surveillance and epidemiology research programs: past, present and future roles.
    Lin AE; Rasmussen SA; Scheuerle A; Stevenson RE
    Birth Defects Res A Clin Mol Teratol; 2009 Jan; 85(1):69-75. PubMed ID: 19107957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assisted reproductive technology and major structural birth defects in the United States.
    Reefhuis J; Honein MA; Schieve LA; Correa A; Hobbs CA; Rasmussen SA;
    Hum Reprod; 2009 Feb; 24(2):360-6. PubMed ID: 19010807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family history in pediatric primary care.
    Trotter TL; Martin HM
    Pediatrics; 2007 Sep; 120 Suppl 2():S60-5. PubMed ID: 17767006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precurrence risk of birth defects in Hawaii.
    Forrester MB; Merz RD
    Congenit Anom (Kyoto); 2008 Mar; 48(1):40-4. PubMed ID: 18230120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.